Prospera Financial Services Inc Pfizer Inc Transaction History

Prospera Financial Services Inc

$3.5 Billion
Q2 2024

A detailed history of Prospera Financial Services Inc transactions in Pfizer Inc stock. As of the latest transaction made, Prospera Financial Services Inc holds 108,562 shares of PFE stock, worth $3.23 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

108,562

Previous 82,962 30.86%

Holding current value

$3.23 Million

Previous $2.39 Million 27.18%

% of portfolio

0.09%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $646,656 - $757,760	25,600 Added 30.86%	108,562 $3.04 Million
Q1 2024 Aug 13, 2024	SELL	$25.89 - $29.73 $343,171 - $394,071	-13,255 Reduced 12.21%	95,307 $2.64 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $2.15 Million - $2.8 Million	-82,423 Reduced 49.84%	82,962 $2.39 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $256,399 - $299,704	7,990 Added 5.08%	165,385 $5.49 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $1.89 Million - $2.18 Million	52,214 Added 49.64%	157,395 $5.77 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $533,576 - $694,638	13,546 Added 14.78%	105,181 $4.29 Million
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $331,870 - $433,220	-7,949 Reduced 7.98%	91,635 $4.7 Million
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $915,240 - $1.12 Million	-20,915 Reduced 17.36%	99,584 $4.36 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $1.22 Million - $1.45 Million	26,286 Added 27.9%	120,499 $6.32 Million
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $2.03 Million - $2.51 Million	-44,313 Reduced 31.99%	94,213 $4.88 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $1.86 Million - $2.76 Million	45,119 Added 48.3%	138,526 $8.18 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $371,540 - $477,275	9,466 Added 11.28%	93,407 $4.02 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $276,507 - $313,236	7,700 Added 10.1%	83,941 $3.29 Million
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $255,394 - $288,034	7,626 Added 11.11%	76,241 $2.76 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $2.29 Million - $2.91 Million	68,424 Added 35824.08%	68,615 $2.53 Million
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $1.63 Million - $1.91 Million	-51,302 Reduced 99.63%	191 $7,000
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $23,945 - $29,049	795 Added 1.57%	51,493 $1.68 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $30,706 - $43,872	-1,136 Reduced 2.19%	50,698 $1.66 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $9,020 - $10,236	274 Added 0.53%	51,834 $2.03 Million
Q3 2019 Oct 22, 2019	BUY	$32.49 - $42.13 $27,129 - $35,178	835 Added 1.65%	51,560 $1.85 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $1.61 Million - $1.81 Million	43,482 New	43,482 $1.89 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $267,846 - $300,729	7,243 Added 16.66%	50,725 $2.21 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $1.63 Million - $1.79 Million	-43,482 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $12,348 - $14,079	321 Added 0.74%	43,482 $1.89 Million
Q3 2018 Oct 25, 2018	SELL	$34.47 - $41.81 $42,156 - $51,133	-1,223 Reduced 2.76%	43,161 $1.75 Million
Q2 2018 Jul 18, 2018	SELL	$32.98 - $35.16 $66,025 - $70,390	-2,002 Reduced 4.32%	44,384 $1.62 Million
Q1 2018 Apr 12, 2018	BUY	$31.91 - $37.02 $293,189 - $340,139	9,188 Added 24.7%	46,386 $1.66 Million
Q4 2017 Jan 24, 2018	BUY	$33.26 - $35.29 $55,910 - $59,322	1,681 Added 4.73%	37,198 $1.36 Million
Q3 2017 Oct 11, 2017	BUY	$31.0 - $34.15 $1.1 Million - $1.21 Million	35,517	35,517 $1.27 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Pfizer Inc Transaction History